Literature DB >> 12379872

The molecular epidemiology of asbestos and tobacco in lung cancer.

Heather H Nelson1, Karl T Kelsey.   

Abstract

Asbestos is a well-known toxin and lung carcinogen. Epidemiologic studies have established tobacco smoke and asbestos exposures synergistically interact to enhance lung cancer risk. The biologic mechanism responsible for this interaction has been the subject of considerable debate. Studies have suggested that asbestos may act as a carcinogen by generating free radical and reactive oxygen species, by inducing tissue injury and subsequent cellular growth, via large-scale chromosome loss and by enhancing delivery of tobacco carcinogens to the respiratory epithelium. Recent molecular epidemiologic approaches further suggest that asbestos enhances the mutagenicity of tobacco carcinogens and that it acts, at least in part, independent of the tissue damage responsible for fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379872     DOI: 10.1038/sj.onc.1205804

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.

Authors:  Gretchen V Gee; Devin C Koestler; Brock C Christensen; David J Sugarbaker; Donatella Ugolini; Giovanni P Ivaldi; Murray B Resnick; E Andres Houseman; Karl T Kelsey; Carmen J Marsit
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

2.  Clinical study of asbestos-related lung cancer diagnosed by asbestos medical examination.

Authors:  Takuma Yotsumoto; Atsushi Sano; Tsutomu Fukuda
Journal:  Cancer Rep (Hoboken)       Date:  2018-07-26

Review 3.  Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Authors:  Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 4.  Molecular basis of asbestos-induced lung disease.

Authors:  Gang Liu; Paul Cheresh; David W Kamp
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

Review 5.  Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?

Authors:  Vanesa C Sanchez; Jodie R Pietruska; Nathan R Miselis; Robert H Hurt; Agnes B Kane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Sep-Oct

Review 6.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Anthony J Alberg; Malcolm V Brock; Jean G Ford; Jonathan M Samet; Simon D Spivack
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

7.  p53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations.

Authors:  Jenni K Peltonen; Henni M Helppi; Paavo Pääkkö; Taina Turpeenniemi-Hujanen; Kirsi H Vähäkangas
Journal:  Head Neck Oncol       Date:  2010-12-15

8.  Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.

Authors:  Penny Nymark; Pamela M Lindholm; Mikko V Korpela; Leo Lahti; Salla Ruosaari; Samuel Kaski; Jaakko Hollmén; Sisko Anttila; Vuokko L Kinnula; Sakari Knuutila
Journal:  BMC Genomics       Date:  2007-03-01       Impact factor: 3.969

Review 9.  Additive Synergism between Asbestos and Smoking in Lung Cancer Risk: A Systematic Review and Meta-Analysis.

Authors:  Yuwadee Ngamwong; Wimonchat Tangamornsuksan; Ornrat Lohitnavy; Nathorn Chaiyakunapruk; C Norman Scholfield; Brad Reisfeld; Manupat Lohitnavy
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

10.  Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression.

Authors:  Beatriz Araujo Cortez; Paula Rezende-Teixeira; Sambra Redick; Stephen Doxsey; Glaucia Maria Machado-Santelli
Journal:  Oncotarget       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.